CATEGORIES

Editors Choice

LATEST

TRENDING

EDITORS CHOICE

Why We Should Be Cautious With COVID-19 Medical Research

Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

Paxlovid for Covid-19: Was I Wrong About Rebound Infection?

Today we explore the remarkable drug Paxlovid before turning to a new report suggesting we were wrong. The drug now appears not associated with a higher probability of COVID-19 re-infection.

The Journey from Analog Patient to Virtual Health Consumer

Provider behavior must follow patient-consumer behavior. Health systems and physicians that are slow to adopt could find themselves quickly falling behind in the healthcare marketplace in the years to come.

Stop Owning a Cancer Diagnosis

Sitting on hold on the phone a few years ago during active cancer treatment to speak to one of my Texas Oncology providers, I...